TSE:KPT

KP Tissue Stock Forecast, Price & News

C$10.39

-0.09 (-0.86 %)

(As of 06/21/2021 04:00 PM ET)

Add

Compare

Today's Range

C$10.37

▼

C$10.44

50-Day Range

C$10.09

▼

C$10.49

52-Week Range

C$10.00

▼

C$14.00

Volume9,383 shs

Average Volume26,567 shs

Market CapitalizationC$101.67 million

P/E RatioN/A

Dividend Yield6.87%

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive KPT News and Ratings via Email

Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter.

About KP Tissue

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.

KP Tissue (TSE:KPT) Stock Crosses Above 200-Day Moving Average of $0.00
June 19, 2021 | americanbankingnews.com

KP Tissue Releases First Quarter 2021 Financial Results
May 7, 2021 | markets.businessinsider.com

Stocks in play: KP Tissue Inc.
May 6, 2021 | ca.finance.yahoo.com

REPEAT: KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the First Quarter of 2021
May 6, 2021 | finance.yahoo.com

KP Tissue Announces Closing of Senior Unsecured Notes Financing
April 8, 2021 | finance.yahoo.com

This Toilet Paper Stock Could Make You a Billionaire
March 14, 2021 | ca.finance.yahoo.com

KP Tissue Releases Fourth Quarter and Full Year 2020 Financial Results
March 11, 2021 | markets.businessinsider.com

REMINDER: KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the Fourth Quarter of 2020
March 10, 2021 | finance.yahoo.com

Kruger Products Successfully Starts up TAD Tissue Plant in Sherbrooke and Announces $240 Million Expansion Project
February 26, 2021 | finance.yahoo.com

Paper Market Analysis, Trends, Growth, Size, Share and Forecast 2020 to 2026
February 2, 2021 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange TSE
Industry Personal Products
Sub-IndustryN/A
SectorConsumer Goods
Current SymbolTSE:KPT
Previous Symbol
CUSIPN/A
CIKN/A
Webkptissueinc.com
Phone+1-905-8126900
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueC$7.98 per share
Price / Book1.30

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares9,785,000
Market CapC$101.67 million
Next Earnings Date8/5/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.05 out of 5 stars

1.0 Analyst's Opinion

Consensus Rating
KP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$11.42, KP Tissue has a forecasted upside of 9.9% from its current price of C$10.39.
Amount of Analyst Coverage
KP Tissue has only been the subject of 4 research reports in the past 90 days.

2.6 Community Rank

Outperform Votes
KP Tissue has received 282 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
KP Tissue has received 255 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
KP Tissue has received 52.51% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about KP Tissue and other stocks. Vote “Outperform” if you believe KPT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe KPT will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
KP Tissue is a leading dividend payer. It pays a dividend yield of 6.87%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
KP Tissue does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, KP Tissue insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of KP Tissue is -41.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of KP Tissue is -41.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
KP Tissue has a PEG Ratio of 1.95. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
KP Tissue has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

KP Tissue (TSE:KPT) Frequently Asked Questions

Is KP Tissue a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" KP Tissue stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares.
View analyst ratings for KP Tissue or view top-rated stocks.

What stocks does MarketBeat like better than KP Tissue?

Wall Street analysts have given KP Tissue a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but KP Tissue wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is KP Tissue's next earnings date?

KP Tissue is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for KP Tissue.

How were KP Tissue's earnings last quarter?

KP Tissue Inc. (TSE:KPT) posted its quarterly earnings results on Friday, May, 7th. The company reported $0.12 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.09 by $0.03. The company earned $310.38 million during the quarter, compared to analyst estimates of $353.30 million.
View KP Tissue's earnings history.

How has KP Tissue's stock been impacted by COVID-19 (Coronavirus)?

KP Tissue's stock was trading at C$11.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, KPT shares have decreased by 6.2% and is now trading at C$10.39.
View which stocks have been most impacted by COVID-19.

How often does KP Tissue pay dividends? What is the dividend yield for KP Tissue?

KP Tissue announced a quarterly dividend on Friday, May 7th. Shareholders of record on Wednesday, June 30th will be given a dividend of 0.18 per share on Thursday, July 15th. This represents a $0.72 annualized dividend and a yield of 6.93%. The ex-dividend date of this dividend is Tuesday, June 29th.
View KP Tissue's dividend history.

Is KP Tissue a good dividend stock?

KP Tissue pays an annual dividend of C$0.72 per share and currently has a dividend yield of 6.87%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View KP Tissue's dividend history.

What price target have analysts set for KPT?

5 equities research analysts have issued 12 month price objectives for KP Tissue's stock. Their forecasts range from C$10.00 to C$13.00. On average, they anticipate KP Tissue's share price to reach C$11.42 in the next year. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for KP Tissue or view top-rated stocks among Wall Street analysts.

Who are KP Tissue's key executives?

KP Tissue's management team includes the following people:

Mr. Dino J. Bianco, Chief Exec. Officer (Age 59, Pay $1.86M)
Mr. Mark Holbrook, Chief Financial Officer
Mr. Michel Manseau, Sr. VP & GM of Consumer Bus. Canada - Kruger Products LP
Mr. Gordon Goss, Sr. VP and GM of Consumer Bus. USA & Mexico - Kruger Products LP
Ms. Susan Irving, Chief Marketing Officer of KPLP
Mr. Marc James Fitzgerald, Corp. VP of Technology & Product Devel. - Kruger Products LP
Mike Baldesarra CPA, CA, Director of Investor Relations
Mr. FranÃ§ois Paroyan, SVP of Gen. Counsel & Corp. Affairs and Corp. Sec.
Mr. Rob Latter, Sr. VP & GM of Away from Home Bus. - Kruger Products LP
Ms. Nancy Marcus, Chief Marketing Officer of Kruger Products LP

Who are some of KP Tissue's key competitors?

Some companies that are related to KP Tissue include Churchill China (CHH), McBride (MCB), Creightons (CRL), Swallowfield (SWL), Byotrol (BYOT), Provexis (PXS), CCA Industries (CAW), Blackmores (BKL), Scott's Liquid Gold (SLGD) and Unilever (UL).
View all of KPT's competitors.

What other stocks do shareholders of KP Tissue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other KP Tissue investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Open Text (OTEX), Rogers Communications (RCI) and Valeant Pharmaceuticals International (VRX).

What is KP Tissue's stock symbol?

KP Tissue trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KPT."

How do I buy shares of KP Tissue?

Shares of KPT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is KP Tissue's stock price today?

One share of KPT stock can currently be purchased for approximately C$10.39.

How much money does KP Tissue make?

KP Tissue has a market capitalization of C$101.67 million.

What is KP Tissue's official website?

The official website for KP Tissue is kptissueinc.com.

Where are KP Tissue's headquarters?

KP Tissue is headquartered at 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada.

How can I contact KP Tissue?

KP Tissue's mailing address is 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada. The company can be reached via phone at +1-905-8126900.

This page was last updated on 6/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here